Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2018-03-12
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI-based Upper Limb Rehabilitation Therapy With MOTORE
NCT05238389
Robotic Therapy and Brain Stimulation in the Early Phase After Stroke
NCT03230695
Robotic Hand Rehabilitation
NCT05983822
Effectiveness of Robot-assisted Rehabilitation in Persons With Stroke
NCT04002076
tDCS and Robotic Therapy in Stroke
NCT01828398
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
The subject receives the Functional Electrical Stimulation (FES) when he or she has the intention to move. It is obtained through electroencephalography.
Neuromodulation electroencephalographic signals and functional electrical stimulation based
First, the subject performs twenty reaching movements without assistance with the damaged arm resting on a robot (ArmeoSpring), with the aim of finding the Contingent Negative Variation (CNV). Then, he or she executes five courses of twenty movements receiving functional electrical stimulation (FES), either at the moment in which he or she wishes to move (experimental group), or half a second before or after (control group).
Control group
The subject receives the Functional Electrical Stimulation (FES) after o before (0.5 seconds) when he or she has the intention to move. It is obtained through electroencephalography.
Neuromodulation electroencephalographic signals and functional electrical stimulation based
First, the subject performs twenty reaching movements without assistance with the damaged arm resting on a robot (ArmeoSpring), with the aim of finding the Contingent Negative Variation (CNV). Then, he or she executes five courses of twenty movements receiving functional electrical stimulation (FES), either at the moment in which he or she wishes to move (experimental group), or half a second before or after (control group).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuromodulation electroencephalographic signals and functional electrical stimulation based
First, the subject performs twenty reaching movements without assistance with the damaged arm resting on a robot (ArmeoSpring), with the aim of finding the Contingent Negative Variation (CNV). Then, he or she executes five courses of twenty movements receiving functional electrical stimulation (FES), either at the moment in which he or she wishes to move (experimental group), or half a second before or after (control group).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cortical or sub-cortical stroke patients
* With a score in the range of 22-44 on Fugl-Meyer scale or 2-4 on the Motor Assessment Scale
* With visible cortical patterns registered by BCI
* Subjects that tolerate electrical stimulation and that present a motor response
* Subjects with cognitive ability to follow instructions and perform the indicated tasks
Exclusion Criteria
* Patients with implanted devices
* Patients with severe motor paralysis
* Patients with epilepsy
* Patient with vision or hearing impairment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro de Referencia Estatal de Atención Al Daño Cerebral
OTHER
Centro Universitario La Salle
OTHER
Cajal Institute of the Spanish National Research Council
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oscar Herrero Gimenez
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose Luis Pons
Role: PRINCIPAL_INVESTIGATOR
Centro Superior de Investigaciones Científicas (CSIC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro de Referencia Estatal de Atención al Daño Cerebral (CEADAC)
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSEULS-PI-106/2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.